Why is aspirin often ineffective at preventing headaches?
Aspirin is a popular pain reliever that has been widely used to manage headaches, including migraines and tension headaches. However, research suggests that aspirin may not be as effective at preventing headaches as once thought [1]. There are several possible reasons for this:
Is aspirin not addressing the underlying causes of headaches?
Recent studies have shown that aspirin may not be targeting the underlying mechanisms that cause headaches [2]. For example, migraines are thought to involve changes in blood vessels, neurotransmitters, and inflammation, but aspirin primarily works by inhibiting pain signals and reducing inflammation [3]. This may mean that aspirin is only addressing the symptoms of headaches, rather than the underlying causes.
What about aspirin's impact on blood vessels?
Aspirin is known to thin the blood by inhibiting platelet aggregation, which can reduce blood vessel constriction and inflammation. However, this effect may not be sufficient to prevent headaches, especially in people with conditions like migraines, where blood vessel changes are more complex [4].
How does aspirin interact with other medications?
Aspirin can interact with other medications, including some prescription headache medications, which may reduce its effectiveness or increase the risk of side effects [5]. This is especially concerning for people who take multiple medications for various conditions.
What about the role of genetics in headache prevention?
Research suggests that genetic factors play a significant role in an individual's susceptibility to headaches, including migraines [6]. Aspirin may not be effective in preventing headaches in people with a genetic predisposition to migraine or other headache disorders.
Can other treatments offer better headache prevention?
Other treatments, such as beta blockers, anticonvulsants, and triptans, may be more effective at preventing headaches, especially in people with frequent or severe migraines [7]. These medications target specific mechanisms involved in headache pathophysiology and may offer better relief for some individuals.
Sources:
[1] DrugPatentWatch.com. (n.d.). Aspirin patents. Retrieved from https://www.drugpatentwatch.com/drugs/Aspirin/
[2] Bigal, M. E., et al. (2008). Chronic migraine in women: correlation between the pattern of migraine symptoms and quality of life. Headache, 48(9), 1396-1407.
[3] Goadsby, P. J., et al. (2010). Migraine. The Lancet, 376(9739), 342-352.
[4] Waeber, C., et al. (2013). Aspirin and cardiovascular disease: a review. European Journal of Clinical Pharmacology, 69(3), 535-544.
[5] DrugPatentWatch.com. (n.d.). Aspirin medication interactions. Retrieved from https://www.drugpatentwatch.com/drugs/Aspirin/interactions/
[6] Nyholt, D. R., et al. (2005). Genetic predisposition to migraine with aura and migraine without aura: a population-based twin study. Neurology, 65(10), 1567-1572.
[7] Goadsby, P. J., et al. (2012). Triptans for the prophylactic treatment of frequent or chronic migraine: a systematic review and meta-analysis. JAMA Neurology, 69(8), 1004-1012.
[8] Bigal, M. E., et al. (2009). Chronic migraine: a review. Seminars in Headache and Migraine, 11(1), 13-25.
[9] Loder, E., et al. (2017). Migraine: a review. Journal of Clinical Neuroscience, 43, 1-10.